Identification of diagnostic serum protein profiles of glioblastoma patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7373
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Identification of diagnostic serum protein profiles of glioblastoma patients ; volume:102 ; number:1 ; day:9 ; month:7 ; year:2010 ; pages:71-80 ; date:3.2011
Journal of neuro-oncology ; 102, Heft 1 (9.7.2010), 71-80, 3.2011
- Urheber
-
Elstner, Anja
Stockhammer, Florian
Nguyen-Dobinsky, Trong-Nghia
Nguyen, Quang Long
Pilgermann, Ingo
Gill, Amanjit
Guhr, Anke
Zhang, Tingguo
Eckardstein, Kajetan von
Picht, Thomas
Veelken, Julian
Martuza, Robert L.
Deimling, Andreas von
Kurtz, Andreas
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11060-010-0284-8
- URN
-
urn:nbn:de:101:1-2021081119052514170748
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elstner, Anja
- Stockhammer, Florian
- Nguyen-Dobinsky, Trong-Nghia
- Nguyen, Quang Long
- Pilgermann, Ingo
- Gill, Amanjit
- Guhr, Anke
- Zhang, Tingguo
- Eckardstein, Kajetan von
- Picht, Thomas
- Veelken, Julian
- Martuza, Robert L.
- Deimling, Andreas von
- Kurtz, Andreas
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Gliomas : [indexed in PubMed-Medline]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Gliomas : [indexed in PubMed-Medline]
In vitro and in vivo modeling of gliomagenesis based on the Idh1R132H mutation
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
In vitro and in vivo modeling of gliomagenesis based on the IDH1R132H mutation
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Klinische und molekularzytogenetische Charakterisierung von Aesthesioneuroblastomen
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches
Gliomas : [indexed in PubMed-Medline]
In vitro and in vivo modeling of gliomagenesis based on the Idh1R132H mutation
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
In vitro and in vivo modeling of gliomagenesis based on the IDH1R132H mutation
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Klinische und molekularzytogenetische Charakterisierung von Aesthesioneuroblastomen
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches
Gliomas : [indexed in PubMed-Medline]
In vitro and in vivo modeling of gliomagenesis based on the Idh1R132H mutation
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
In vitro and in vivo modeling of gliomagenesis based on the IDH1R132H mutation
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Klinische und molekularzytogenetische Charakterisierung von Aesthesioneuroblastomen
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status